Skip to Main Content
Full Text View
Contacts and Locations
No Study Results Posted
Intramuscular Injections of Risperidone 4-Week Long-Acting Injectable (LAI) Formulation in the Buttock of Subjects With Schizophrenia
This study is currently recruiting participants.
Study NCT00821600. Last updated on January 13, 2009.
Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
risperidone 4-week LAI formulation
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Depressants
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs
Sponsors listed in this trial
Johnson &Johnson Pharmaceutical Research &Development, L.L.C.
Back to top of Main Content
U.S. National Library of Medicine
Contact Help Desk
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers